Venture Capitalists News Hubb
Advertisement Banner
  • Home
  • Venture Capital Market
  • Venture Capital Funding
  • Contact
No Result
View All Result
  • Home
  • Venture Capital Market
  • Venture Capital Funding
  • Contact
No Result
View All Result
Venture Capitalists News Hubb
No Result
View All Result
Home Venture Capital Market

The Capital Quest | KKR to buy UK arm of Apax-backed Healthium Medtech

admin by admin
December 6, 2022
in Venture Capital Market


Alternative investment firm KKR said Tuesday it has agreed to acquire Clinisupplies, a market leader in continence care products in the UK, from Healthium Medtech, an initial public offering (IPO) bound company that is controlled by PE major Apax.

Clinisupplies’ management team will continue to hold a minority position. Financial details of the transaction were not disclosed.

Clinisupplies is a UK-based manufacturer and distributor of continence care products, including urinary collecting devices and catheters. Clinisupplies’ products are supplied to hospitals and pharmacies, while also available for delivery to patients directly through its home delivery services – Clinidirect. It is headquartered in Watford, London, and employs over 400 employees.

Healthium via another unit had acquired the firm in 2016 from Hemang Badiani. Although the deal value was not disclosed, it was believed to be in the region of $15-20 million.

Last year, Clinisupplies acquired VitalCare for an aggregate consideration of up to ₤9.25 million, equivalent to approximately Rs 95.3 crore then, besides certain other items including cash in hand and cash equivalents. VitalCare is engaged in the business of manufacturing and sales of white labelled urology and anal irrigation product.

This deal was supported by a loan from Apax, which was to be partly repaid from the proceeds of the proposed IPO of Healthium. With this deal, the IPO size could be tweaked.

Claus Bjerre, KKR Senior Advisor and former Chief Executive Officer of Atos Medical AB and former President, North America, of Coloplast, will serve as Chairman of Clinisupplies’ board. KKR will also rope in industry veteran Douglas Le Fort to the board.

Paul Cook, CEO of Clinisupplies, commented: “With KKR’s global network and market knowledge, and with this strong suite of industry advisors, we will be able to expand into new products and geographies, helping to support more and more people and bringing us one step closer to our goal of becoming an international leader in the chronic care market.”

Claus Bjerre, KKR Senior Advisor, commented: “Clinisupplies has an industry leading track record as a fully integrated provider of continence care solutions to clinics and patients across the UK. Its business model covers the entire value chain, from R&D and manufacturing to direct-to-patient sales and distribution, allowing the group to continuously understand and address the evolving needs of patients, clinicians, and caregivers alike.”

KKR is investing in Clinisupplies through KKR Health Care Strategic Growth Fund II, a $4 billion fund focused on investing in high-growth health care companies. KKR has a long track record of supporting health care companies globally, having invested approximately $17 billion in the sector since 2004.

KKR was advised by Houlihan Lokey (financial advisor), Gibson, Dunn & Crutcher LLP (legal counsel), PWC (financial & tax) and BCG (commercial). RBC Capital Markets was the lead financial adviser and Kirkland & Ellis the lead legal adviser to Apax and Healthium Medtech for this deal.

Related



Source link

Previous Post

Maple Finance Says Orthogonal Hid FTX Exposure

Next Post

Masterclass: Making healthcare smarter

Next Post

Masterclass: Making healthcare smarter

Recommended

The Capital Quest | Seqoon, Omnisient, other African startups raise cash; 54gene in trouble

3 months ago

Unacademy to launch NextLevel to take on LinkedIn

2 months ago

Bengaluru may see highest growth in office rent in Asia-Pacific region at 5-7% next year: Report

2 months ago

BlockFi Exec To Lead Google Cloud’s Web3 Efforts Across Asia-Pacific

2 months ago
[Weekly funding roundup Aug 29-Sept 2] Venture capital inflow into Indian startups remains subdued

[Weekly funding roundup Aug 29-Sept 2] Venture capital inflow into Indian startups remains subdued

5 months ago

The Capital Quest | Mezz fund manager Vantage exits from maiden bet in Francophone Africa

3 weeks ago

© 2022 Venture CapitaLists News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • Venture Capital Market
  • Venture Capital Funding
  • Contact

Newsletter Sign Up.

No Result
View All Result
  • Home
  • Venture Capital Market
  • Venture Capital Funding
  • Contact

© 2022 Venture Capitalists News Hubb All rights reserved.